Spirodiketopiperazine-based CCR5 antagonists: Improvement of their pharmacokinetic profiles

被引：17

作者：

Nishizawa, Rena ^{[1
]}

Nishiyama, Toshihiko ^{[1
]}

Hisaichi, Katsuya ^{[1
]}

Hirai, Keisuke ^{[1
]}

Habashita, Hiromu ^{[1
]}

Takaoka, Yoshikazu ^{[3
]}

Tada, Hideaki ^{[2
]}

Sagawa, Kenji ^{[4
]}

Shibayama, Shiro ^{[2
]}

Maeda, Kenji ^{[5
,6
]}

Mitsuya, Hiroaki ^{[5
,6
]}

Nakai, Hisao ^{[1
]}

Fukushima, Daikichi ^{[1
]}

Toda, Masaaki ^{[1
]}

机构：

[1] Ono Pharmaceut Co Ltd, Minase Res Inst, Osaka 6188585, Japan

[2] Ono Pharmaceut Co Ltd, Tsukuba Res Inst, Ibaraki 300424, Japan

[3] Ono Pharmaceut Co Ltd, Fukui Res Inst, Fukui 9138538, Japan

[4] Ono Pharmaceut Co Ltd, Osaka 5410056, Japan

[5] Kumamoto Univ, Sch Med, Dept Internal Med 2, Kumamoto 8600811, Japan

[6] NCI, Expt Retrovirol Sect, HIV & AIDS Malignancy Branch, NIH, Bethesda, MD 20892 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 02期

关键词：

CCR5; Chemokine; Anti HIV-1; HIV-1; ENTRY; CORECEPTOR; COFACTOR; RECEPTOR; POTENT;

D O I：

10.1016/j.bmcl.2009.11.018

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Spirodiketopiperazine-based CCR5 antagonists, showing improved pharmacokinetic profiles without reduction in antagonist activity, were designed and synthesized. We also demonstrate the anti-HIV activity of a representative compound 12, as measured in a p24 assay. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：763 / 766

页数：4

共 50 条

[31] CCR5 antagonists in the treatment of treatment-experienced patients infected with CCR5 tropic HIV-1
Lorenzen, Thore
Stoehr, Albrecht
Walther, Irene
Plettenberg, Andreas
EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2007, 12 (09) : 419 - 425
[32] Molecular interactions of CCR5 with major classes of small-molecule anti-HIV CCR5 antagonists
Kondru, Rama
Zhang, Jun
Ji, Changhua
Mirzadegan, Tara
Rotstein, David
Sankuratri, Surya
Dioszegi, Marianna
MOLECULAR PHARMACOLOGY, 2008, 73 (03) : 789 - 800
[33] CCR5 antagonists in the treatment of treatment-naive patients infected with CCR5 tropic HIV-1
Bredeek, U. Fritz
Harbour, Michael J.
EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2007, 12 (09) : 427 - 434
[34] Discovery of CCR5 antagonists containing the aminoguanidine group.
Kesicki, EA
Odingo, JO
Oliver, AR
Orme, MW
Schweickart, VL
Epp, A
Gray, PW
Fowler, KW
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U19 - U19
[35] Advances of CCR5 antagonists: From small molecules to macromolecules
Qi, Baowen
Fang, Qiang
Liu, Shiyuan
Hou, Wenli
Li, Jian
Huang, Yingchun
Shi, Jianyou
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 208
[36] The discovery of tropane-derived CCR5 receptor antagonists
Armour, DR
de Groot, MJ
Price, DA
Stammen, BLC
Wood, A
Perros, M
Burt, C
CHEMICAL BIOLOGY & DRUG DESIGN, 2006, 67 (04) : 305 - 308
[37] Allosteric effects of antagonists on signalling by the chemokine receptor CCR5
Haworth, Ben
Lin, Hong
Fidock, Mark
Dorr, Pat
Strange, Philip G.
BIOCHEMICAL PHARMACOLOGY, 2007, 74 (06) : 891 - 897
[38] CCR5 cell surface density and HIV-1 envelope sequences govern antiretroviral potency of CCR5 antagonists
Miller, MD
Lineberger, JE
Dornadula, G
Danzeisen, RC
Blau, CR
Danovich, RM
Miller, MA
Finke, PE
Oates, BD
Caldwell, CG
Chen, P
Meurer, LC
Mills, SG
Springer, MS
Petropoulos, CJ
Whitcomb, J
Huang, W
Fransen, S
Simon, AJ
Hazuda, DJ
ANTIVIRAL THERAPY, 2003, 8 (03) : U66 - U67
[39] Primary genotypic resistance of HIV-1 to CCR5 antagonists in CCR5 antagonist treatment-naive patients
Soulie, Cathia
Malet, Isabelle
Lambert-Niclot, Sidonie
Tubiana, Roland
Thevenin, Monique
Simon, Anne
Murphy, Robert
Katlama, Christine
Calvez, Vincent
Marcelin, Anne-Genevieve
AIDS, 2008, 22 (16) : 2212 - 2214
[40] Differential Use of CCR5 by HIV-1 Clinical Isolates Resistant to Small-Molecule CCR5 Antagonists
Henrich, Timothy J.
Lewine, Nicolas R. P.
Lee, Sun-Hee
Rao, Suhas S. P.
Berro, Reem
Gulick, Roy M.
Moore, John P.
Tsibris, Athe M. N.
Kuritzkes, Daniel R.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (04) : 1931 - 1935

← 1 2 3 4 5 →